ONCOLYS BIOPHARMA INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 655 JPY | -1.06% |
|
-4.66% | +15.52% |
Chart calendar Oncolys BioPharma Inc.
f6156.RNdSW2HcYmMk9jq_Lio2MfR7xytK57VKgucecgH8t-o.fOEwMRKEUgtQrGr-Y2JUR5BLlEJnptF8zd5bPjCoj4ki-iEQBugoVxCyYw~b83e30d993b03787ad974c58bc4dbdd0
Upcoming events on Oncolys BioPharma Inc.
Past events on Oncolys BioPharma Inc.
| 09/05/2024 | Q1 2024 Earnings Release |
| 08/02/2024 | Q4 2023 Earnings Release |
| 09/11/2023 | Q3 2023 Earnings Release |
| 03/08/2023 | Q2 2023 Earnings Release |
| 11/05/2023 | Q1 2023 Earnings Release |
| 09/02/2023 | Q4 2022 Earnings Release |
| 03/11/2022 | Q3 2022 Earnings Release |
| 04/08/2022 | Interim 2022 Earnings Release |
| 12/05/2022 | Q1 2022 Earnings Release |
| 09/02/2022 | FY 2021 Earnings Release |
| 04/11/2021 | Q3 2021 Earnings Release |
| 05/08/2021 | Interim 2021 Earnings Release |
| 06/05/2021 | Q1 2021 Earnings Release |
| 11/02/2021 | FY 2020 Earnings Release |
| 05/11/2020 | Q3 2020 Earnings Release |
| 06/08/2020 | Interim 2020 Earnings Release |
| 07/05/2020 | Q1 2020 Earnings Release |
| 31/10/2019 | Q3 2019 Earnings Release |
| 01/08/2019 | Interim 2019 Earnings Release |
| 09/05/2019 | Q1 2019 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 168 230 -26.96% | 1 303 1 200 8.58% | 314 300 4.67% | 642 400 60.5% | 976 | 63,0 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million JPY | Released Forecast Spread | -1 247 -1 400 10.93% | -511 -400 -27.75% | -1 674 -1 200 -39.5% | -1 454 -1 800 19.22% | -1 204 | -1 929 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -1 230 0,00 - | -908 0,00 - | -2 091 0,00 - | -1 611 0,00 - | -1 146 | -1 935 |
|
Net income Million JPY | Released Forecast Spread | -1 233 -1 400 11.93% | -912 -400 -128% | -2 095 -1 200 -74.58% | -1 615 -1 800 10.28% | -1 148 | -1 938 |
|
EPS JPY | Released Forecast Spread | -105 -118 11.7% | -65,6 -29,0 -126.03% | -146 -83,4 -74.56% | -95,5 -113 15.34% | -66,3 | -109 |
| Announcement Date | 08/02/19 | 07/02/20 | 12/02/21 | 10/02/22 | 10/02/23 | 09/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q1 | 2021 Q3 | 2022 Q1 | 2022 Q3 | 2023 Q1 |
|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 62,0 | 125 | 193 | 358 | 35,0 |
|
EBIT Million JPY | Released Forecast Spread | -349 | -330 | -384 | -279 | -325 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -349 | -327 | -328 | -264 | -322 |
|
Net income Million JPY | Released Forecast Spread | -350 | -329 | -328 | -265 | -323 |
|
EPS JPY | Released Forecast Spread | -22,4 | -19,0 | -19,0 | -15,3 | -18,7 |
| Announcement Date | 07/05/21 | 05/11/21 | 13/05/22 | 04/11/22 | 12/05/23 |
| 11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 15/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 22/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
| 23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
| 25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Oncolys BioPharma Inc.
| 14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 12/05/2024 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 07:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 08/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4588 Stock
- Calendar Oncolys BioPharma Inc.
